ストックスクリーナーアプリを入手
28.24
0.84%
-0.24
アフターアワーズ：
28.25
0.01
+0.04%
前日終値:
$28.48
開ける：
$28.41
24時間の取引高:
914.87K
Relative Volume:
0.88
時価総額：
$26.86B
収益：
$20.19B
当期純損益:
$1.03B
株価収益率:
26.42
EPS:
1.0687
ネットキャッシュフロー:
$966.68M
1週間 パフォーマンス:
-2.92%
1か月 パフォーマンス:
+7.58%
6か月 パフォーマンス:
-1.16%
1年 パフォーマンス:
+16.98%
1日の値動き範囲:
$28.09
$28.48
1週間の範囲:
$28.09
$29.95
52週間の値動き範囲:
$21.95
$33.44
Koninklijke Philips Nv Adr Stock (PHG) Company Profile
Compare PHG vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips Nv Adr
|
28.24 | 27.09B | 20.19B | 1.03B | 966.68M | 1.0687 |
ABT
Abbott Laboratories
|
91.70 | 161.12B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
329.35 | 125.35B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
83.22 | 105.28B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.87 | 88.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.53 | 45.96B | 6.07B | 1.06B | 1.34B | 1.8063 |
Koninklijke Philips Nv Adr Stock (PHG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-17 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-02-25 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | アップグレード | UBS | Neutral → Buy |
| 2024-10-29 | アップグレード | Jefferies | Underperform → Hold |
| 2024-05-13 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | アップグレード | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-04-30 | アップグレード | UBS | Sell → Neutral |
| 2024-02-07 | ダウングレード | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | 開始されました | Goldman | Buy |
| 2023-01-17 | ダウングレード | UBS | Neutral → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-14 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2022-09-12 | アップグレード | Societe Generale | Hold → Buy |
| 2022-09-06 | アップグレード | UBS | Sell → Neutral |
| 2022-07-25 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-06-16 | ダウングレード | UBS | Neutral → Sell |
| 2022-01-20 | ダウングレード | Jefferies | Buy → Hold |
| 2022-01-14 | アップグレード | HSBC Securities | Hold → Buy |
| 2022-01-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-09-08 | 開始されました | Jefferies | Buy |
| 2021-07-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-06-21 | ダウングレード | HSBC Securities | Buy → Hold |
| 2021-03-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-07-28 | 開始されました | Societe Generale | Buy |
| 2019-07-30 | 開始されました | Citigroup | Buy |
| 2018-02-12 | アップグレード | Berenberg | Hold → Buy |
| 2017-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-10-16 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | ダウングレード | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | ダウングレード | Societe Generale | Buy → Hold |
| 2016-12-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | 開始されました | Citigroup | Buy |
| 2016-05-11 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | アップグレード | HSBC Securities | Reduce → Hold |
| 2016-02-16 | ダウングレード | Jefferies | Hold → Underperform |
| 2015-11-27 | 開始されました | ING Group | Hold |
| 2015-09-08 | 開始されました | Credit Suisse | Outperform |
| 2015-08-27 | アップグレード | Nomura | Neutral → Buy |
| 2015-07-28 | アップグレード | Societe Generale | Hold → Buy |
| 2011-01-25 | ダウングレード | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2009-10-16 | アップグレード | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | ダウングレード | UBS | Buy → Neutral |
すべてを表示
Koninklijke Philips Nv Adr (PHG) 最新ニュース
Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight - GlobeNewswire Inc.
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finviz
Koninklijke Philips (ADR) stock (NL0000009538): Why Google Discover changes matter more now - AD HOC NEWS
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Sahm
Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Finviz
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on diagnostics and AI tools matters mo - AD HOC NEWS
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on healthcare innovation matters more - AD HOC NEWS
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Koninklijke Philips N.V. (PHG) Stock Price, News, Quote & History - Yahoo! Finance Canada
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member - Sahm
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - Finviz
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant - Sahm
Philips convenes the Annual General Meeting of Shareholders 2026 - Finviz
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - Finviz
Sony Group Corp. ADR falls Wednesday, underperforms market - MarketWatch
Sony Group Corp. ADR falls Tuesday, underperforms market - MarketWatch
Koninklijke Philips (ADR) Stock Gains Traction as Earnings Beat Expectations Amid Health Tech Recove - AD HOC NEWS
PHIA Stock Price and Chart — EURONEXT:PHIA - TradingView
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite - Finviz
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 - Finviz
Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction - Finviz
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments - Finviz
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments - Finviz
Owlet Stock Before Q4 Earnings: Buy Now or Wait for Results? - Finviz
Philips introduces InkSpace Imaging's Snuggle flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort - Finviz
Philips (PHG) Soars to 52-Week High on Strong Earnings, Upbeat Outlook - Finviz
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments - Finviz
Earnings call transcript: Philips Q4 2025 earnings beat EPS forecasts - Investing.com
Philips proposes to re-appoint CEO Roy Jakobs - Finviz
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment - Finviz
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year - Finviz
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
Koninklijke Philips Nv Adr (PHG) 財務データ
収益
当期純利益
現金流量
EPS
1.29%
1.22%
大文字化:
|
ボリューム (24 時間):